Baseline characteristics in the Bardoxolone methyl EvAluation in patients with Chronic kidney disease and type 2 diabetes mellitus: The Occurrence of renal eveNts (BEACON) trial
Hiddo J Lambers Heerspink, Glenn M. Chertow, Tadao Akizawa, Paul Audhya, George L. Bakris, Angie Goldsberry, Melissa Krauth, Peter Linde, John J. McMurray, Colin J. Meyer, Hans Henrik Parving, Giuseppe Remuzzi, Heidi Christ-Schmidt, Robert D. Toto, Nosratola D. Vaziri, Christoph Wanner, Janet Wittes, Danielle Wrolstad, Dick De Zeeuw
Dive into the research topics of 'Baseline characteristics in the Bardoxolone methyl EvAluation in patients with Chronic kidney disease and type 2 diabetes mellitus: The Occurrence of renal eveNts (BEACON) trial'. Together they form a unique fingerprint.